APA (7th ed.) Citation

H, J., Y, F., Y, H., D, B., EJ, K., I, H., . . . PB, G. (2026). Correlates of severe and delta COVID-19 in a phase 3 trial of the AZD1222 vaccine. NPJ vaccines, 11(1), . https://doi.org/10.1038/s41541-026-01411-1

Chicago Style (17th ed.) Citation

H, Janes, et al. "Correlates of Severe and Delta COVID-19 in a Phase 3 Trial of the AZD1222 Vaccine." NPJ Vaccines 11, no. 1 (2026). https://doi.org/10.1038/s41541-026-01411-1.

MLA (9th ed.) Citation

H, Janes, et al. "Correlates of Severe and Delta COVID-19 in a Phase 3 Trial of the AZD1222 Vaccine." NPJ Vaccines, vol. 11, no. 1, 2026, https://doi.org/10.1038/s41541-026-01411-1.